News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
507 Results
Type
Article (15)
Press Release (492)
Section
Business (184)
Deals (19)
Drug Development (157)
FDA (2)
Job Trends (4)
News (321)
Policy (25)
Tag
Alliances (50)
Approvals (2)
Best Places to Work (2)
Cancer (12)
Clinical research (125)
COVID-19 (1)
Data (15)
Earnings (114)
Events (80)
FDA (3)
Government (3)
Healthcare (2)
Immuno-oncology (1)
Infectious disease (1)
IPO (17)
Job creations (2)
Legal (1)
Lung cancer (1)
Lymphoma (9)
Mergers & acquisitions (2)
NextGen: Class of 2026 (1)
Ovarian cancer (1)
People (24)
Phase 1 (70)
Phase 2 (85)
Phase 3 (15)
Pipeline (4)
Preclinical (17)
Real estate (1)
Regulatory (24)
Startups (2)
Date
Last 365 days (30)
2026 (1)
2025 (29)
2024 (18)
2023 (37)
2022 (50)
2021 (55)
2020 (56)
2019 (34)
2018 (11)
2017 (10)
2016 (26)
2015 (23)
2014 (11)
2013 (18)
2012 (31)
2011 (19)
2010 (16)
Location
Africa (1)
Asia (25)
Australia (1)
California (2)
Europe (466)
Northern California (2)
United States (2)
507 Results for "bioinvent".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BioInvent to Participate in Upcoming January 2026 Investor Conference
December 19, 2025
·
1 min read
Press Releases
BioInvent International AB: Interim Report January - September 2025
October 29, 2025
·
3 min read
Press Releases
Invitation to Presentation of BioInvent’s Interim Report January - September 2025
October 28, 2025
·
2 min read
Press Releases
BioInvent Reports Promising Data from Ongoing Phase 2a study for BI-1808 with KEYTRUDA(R) (pembrolizumab) in Recurrent Ovarian Cancer
January 5, 2026
·
7 min read
Press Releases
BioInvent Presents Promising Early Phase 2a BI-1808 Monotherapy Data in CTCL at ASH 2025
December 8, 2025
·
6 min read
Press Releases
BioInvent Announces Board of Directors Update
September 2, 2025
·
2 min read
Press Releases
EMA Positive Opinion for Orphan Drug Designation to BioInvent’s BI‑1808 for the Treatment of Cutaneous T-cell Lymphoma
November 17, 2025
·
5 min read
Press Releases
BioInvent to Present Updated Phase 2a BI-1808 Monotherapy Data in CTCL at ASH 2025
November 4, 2025
·
5 min read
Press Releases
BioInvent Announces Publication of Preclinical and Early Phase 1 Data for BI-1607 in HER2-Positive Advanced Solid Tumors
November 19, 2025
·
6 min read
Press Releases
BioInvent Presents Impressive Response Data from Ongoing Phase 2a Trial of Triple Combination BI-1206, Rituximab, and Calquence in r/r NHL at ASH 2025
December 8, 2025
·
6 min read
1 of 51
Next
